Xiaoxiao Ma

2.9k total citations
45 papers, 1.1k citations indexed

About

Xiaoxiao Ma is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaoxiao Ma has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Immunology. Recurrent topics in Xiaoxiao Ma's work include Glioma Diagnosis and Treatment (4 papers), MicroRNA in disease regulation (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Xiaoxiao Ma is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), MicroRNA in disease regulation (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Xiaoxiao Ma collaborates with scholars based in China, United States and Germany. Xiaoxiao Ma's co-authors include Wendong Huang, Carl Van Ness, Lihui Han, Heying Zhang, Yanhong Shi, Guoqiang Sun, Allen Wang, Jason Z. Yin, Zhipeng Meng and Kiyohito Murai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Xiaoxiao Ma

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxiao Ma China 17 666 287 255 184 162 45 1.1k
Silvia Schauer Austria 21 897 1.3× 345 1.2× 223 0.9× 142 0.8× 178 1.1× 41 1.7k
Jiping Qi China 25 716 1.1× 302 1.1× 315 1.2× 185 1.0× 167 1.0× 73 1.5k
Xavier Deschênes‐Simard Canada 11 1.0k 1.6× 255 0.9× 368 1.4× 300 1.6× 169 1.0× 18 1.8k
Anna Garuti Italy 21 644 1.0× 254 0.9× 477 1.9× 297 1.6× 122 0.8× 67 1.5k
Mathias Dahlmann Germany 16 622 0.9× 205 0.7× 360 1.4× 124 0.7× 120 0.7× 30 1.1k
Praphulla Chandra Shukla India 17 784 1.2× 333 1.2× 182 0.7× 221 1.2× 262 1.6× 39 1.8k
Harald J. Maier Germany 16 613 0.9× 280 1.0× 333 1.3× 191 1.0× 88 0.5× 27 1.1k
David Vindrieux France 19 673 1.0× 172 0.6× 251 1.0× 213 1.2× 96 0.6× 35 1.2k
Rangnath Mishra United States 19 767 1.2× 119 0.4× 186 0.7× 138 0.8× 115 0.7× 40 1.4k
Yan Xia United States 16 750 1.1× 406 1.4× 230 0.9× 197 1.1× 228 1.4× 22 1.3k

Countries citing papers authored by Xiaoxiao Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoxiao Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiao Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiao Ma more than expected).

Fields of papers citing papers by Xiaoxiao Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiao Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiao Ma. The network helps show where Xiaoxiao Ma may publish in the future.

Co-authorship network of co-authors of Xiaoxiao Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiao Ma. A scholar is included among the top collaborators of Xiaoxiao Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiao Ma. Xiaoxiao Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Xiaoxiao, et al.. (2025). BDEC: Brain Deep Embedded Clustering Model for Resting State fMRI Group-Level Parcellation of the Human Cerebral Cortex. IEEE Transactions on Biomedical Engineering. 73(2). 644–657.
2.
Zhang, Xiaojing, Ying Liu, Xin Zhang, et al.. (2024). Structural characterization and anti-ageing activity of polysaccharide from Exocarpium Citrulli. Journal of Molecular Structure. 1316. 139073–139073. 6 indexed citations
3.
Ma, Xiaoxiao, et al.. (2024). Comparative Efficacy of Micro-Needle-Knife Therapy and Acupuncture in Acute Ankle Sprains: A Randomized Controlled Trial. Medical Science Monitor. 30. e944157–e944157. 2 indexed citations
4.
Kang, Yan, et al.. (2024). Development of non-animal chicken fat using faba bean protein-based emulsion gels. LWT. 214. 117124–117124.
5.
6.
Ma, Xiaoxiao, Gang Cheng, Chenxi Li, et al.. (2023). Apparent Diffusion Coefficient as Imaging Biomarker for Identifying IDH Mutation, 1p19q Codeletion, and MGMT Promoter Methylation Status in Patients With Glioma. Journal of Magnetic Resonance Imaging. 58(3). 732–738. 8 indexed citations
7.
Ma, Xiaoxiao, S. Yu, Jin Gu, Hong Jiang, & Y. Shan. (2023). AB0564 TIGIT ACTIVATOR ALLEVIATES SYSTEMIC LUPUS ERYTHEMATOSUS BY NEGATIVELY REGULATING TH1-LIKE TREG CELL DIFFERENTIATION. Annals of the Rheumatic Diseases. 82. 1479–1479. 1 indexed citations
8.
Alban, Tyler, Nadeem Riaz, Vlad Makarov, et al.. (2023). Abstract 1125: Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab. Cancer Research. 83(7_Supplement). 1125–1125. 1 indexed citations
9.
Meng, Zhipeng, Cao Fang, Yunjiang Qiu, et al.. (2022). The Hippo pathway mediates Semaphorin signaling. Science Advances. 8(21). eabl9806–eabl9806. 12 indexed citations
10.
Ma, Xiaoxiao & Timothy A. Chan. (2022). Solving the puzzle of what makes immunotherapies work. Trends in cancer. 8(11). 890–900. 6 indexed citations
11.
Ding, Lili, Eryun Zhang, Qiaoling Yang, et al.. (2021). Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice. Proceedings of the National Academy of Sciences. 118(6). 36 indexed citations
12.
Sabio, Erich, Chirag Krishna, Xiaoxiao Ma, et al.. (2021). Qa-1b Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing. Molecular Cancer Research. 19(6). 1076–1084. 13 indexed citations
13.
Ma, Xiaoxiao, et al.. (2021). Regulation of blood-brain barrier permeability by Salvinorin A via alleviating endoplasmic reticulum stress in brain endothelial cell after ischemia stroke. Neurochemistry International. 149. 105093–105093. 14 indexed citations
14.
Qiu, Yumin, Peishu Liu, Xiaomin Ma, et al.. (2019). TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(9). 1412–1420. 22 indexed citations
15.
Wang, Zhenhong, et al.. (2018). Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK. Molecular Medicine Reports. 18(4). 3957–3964. 32 indexed citations
16.
Guo, Pengbo, Yumin Qiu, Xiaomin Ma, et al.. (2018). Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis. Experimental Cell Research. 368(1). 59–66. 32 indexed citations
17.
Huang, Xiongfei, Xinrui Wang, Xiaoxiao Ma, et al.. (2016). FXR blocks the growth of liver cancer cells through inhibiting mTOR-s6K pathway. Biochemical and Biophysical Research Communications. 474(2). 351–356. 19 indexed citations
18.
Lou, Guiyu, Xiaoxiao Ma, Xianghui Fu, et al.. (2014). GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells. PLoS ONE. 9(4). e93567–e93567. 70 indexed citations
19.
Akeno, Nagako, Ashley L. Miller, Xiaoxiao Ma, & Kathryn A. Wikenheiser‐Brokamp. (2014). p53 suppresses carcinoma progression by inhibiting mTOR pathway activation. Oncogene. 34(5). 589–599. 48 indexed citations
20.
Meng, Zhipeng, Tao Li, Xiaoxiao Ma, et al.. (2013). Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II. Molecular Cancer Therapeutics. 12(10). 2067–2077. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Schauer Breakdown of academic impact, for papers by Jiping Qi Breakdown of academic impact, for papers by Xavier Deschênes‐Simard Breakdown of academic impact, for papers by Anna Garuti Breakdown of academic impact, for papers by Mathias Dahlmann Breakdown of academic impact, for papers by Praphulla Chandra Shukla Breakdown of academic impact, for papers by Harald J. Maier Breakdown of academic impact, for papers by David Vindrieux Breakdown of academic impact, for papers by Rangnath Mishra Breakdown of academic impact, for papers by Yan Xia
Rankless by CCL
2026